Description

DAILYVOG M Tablet is a dual oral antidiabetic for type 2 diabetes, designed to control both fasting and post-meal blood glucose levels when diet, exercise, or single-agent therapy are inadequate.

Uses / Indications

Type 2 diabetes mellitus: For adults to improve glycemic control and reduce risks of complications such as eye, kidney, nerve, and heart disease.
Especially helpful for patients with prominent postprandial (after-meal) sugar elevations.

How it Works / Key Benefits

Metformin (SR): Reduces liver glucose output, improves the body’s response to insulin, and slows the intestinal absorption of sugars for better overall sugar management.
Voglibose: Delays digestion of carbohydrates in the intestine by blocking alpha-glucosidase, flattening post-meal blood sugar spikes.
The combination helps maintain more stable blood glucose and reduces long-term diabetes complications.

Dosage & Administration

Typically taken once or twice daily with meals, as prescribed by the physician.
Swallow whole with water—do not split, crush, or chew.
Adherence is vital for glycemic control; do not stop abruptly.
Continue regular exercise, diet, and blood sugar monitoring throughout therapy.

Safety & Side Effects

Common: Diarrhea, nausea, vomiting, gas, stomach pain, taste changes, mild rash, decreased appetite.
Uncommon: Signs of low blood sugar (dizziness, sweating, confusion), more likely if combined with other antidiabetic drugs.
Not recommended for type 1 diabetes, diabetic ketoacidosis, severe kidney/liver impairment, chronic digestive issues, pregnancy/breastfeeding, or if allergic to ingredients.
Avoid alcohol and monitor kidney/liver function regularly.

Note:
DAILYVOG M supports stable blood sugar as part of an integrated diabetes management plan—use only as directed and alongside diet and lifestyle modifications for optimal safety and effectiveness.